SIGN UP
LOG IN
MARKET
ANIK
ANIK
Anika Therapeutics Inc
NASDAQ
22.66
+0.75
+3.42%
Closed 16:01 12/01 EST
OPEN
21.93
PREV CLOSE
21.91
HIGH
22.79
LOW
21.80
VOLUME
93.54K
TURNOVER
0
52 WEEK HIGH
32.33
52 WEEK LOW
16.54
MARKET CAP
331.76M
P/E (TTM)
-13.5042
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ANIK last week (1127-1201)?
Weekly Report · 7h ago
Anika Announces First Surgeries Performed Using The Integrity Implant System, A Regenerative Hyaluronic Acid-Based Patch System For Rotator Cuff Repairs, Commencing Limited Market Release
Integrity marks anika's entrance into the fast-growing $150 million+2 u.s. Rotator cuff augmentation market and expansion of its hyaluronic acid regenerative portfolio. The first surgeries using the integrity implant system were successfully performed at the florida orthopaedic institute in tampa, fl. Anika is a global joint preservation company focused on early intervention orthopedics.
Benzinga · 6d ago
Weekly Report: what happened at ANIK last week (1120-1124)?
Weekly Report · 11/27 09:09
Weekly Report: what happened at ANIK last week (1113-1117)?
Weekly Report · 11/20 09:09
Weekly Report: what happened at ANIK last week (1106-1110)?
Weekly Report · 11/13 09:09
Strong week for Anika Therapeutics (NASDAQ:ANIK) shareholders doesn't alleviate pain of five-year loss
Anika therapeutics, inc.'s share price is up 14% in the last month, but shareholders have lost 41% over the last five years. its share price has under-performed the market by 7% per year, despite growing revenue at 9.4% over that period. the company didn't make a profit in the past 12 months, but revenue growth has been strong over the years.
Simply Wall St · 11/06 15:00
Weekly Report: what happened at ANIK last week (1030-1103)?
Weekly Report · 11/06 09:09
Barrington Research Maintains Outperform on Anika Therapeutics, Raises Price Target to $28
Benzinga · 11/03 16:05
About ANIK
Anika Therapeutics, Inc. is a joint preservation company. The Company is engaged in creating and delivering advancements in early intervention orthopedic care, including osteoarthritis (OA) pain management, regenerative solutions, sports medicine and Arthrosurface joint solutions. The Company is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. The Company’s product line includes OA Pain Management, Joint Preservation and Restoration, and Non-Orthopedic. Its OA Pain Management product consists of Monovisc and Orthovisc, Cingal, and Hyvisc. Its Joint Preservation and Restoration consist of regenerative solutions, sports medicine, and Arthrosurface joint solutions. Monovisc and Orthovisc are single and multi-injection, HA-based Visco supplement products, Cingal, and Hyvis. Its Non-Orthopedic products consists of HA-based products that are marketed principally for non-orthopedic applications.
Webull offers Anika Therapeutics Inc stock information, including NASDAQ: ANIK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading ANIK stock methods without spending real money on the virtual paper trading platform.